Literature DB >> 15655668

Evolutionary conservation and characterization of the bare lymphocyte syndrome transcription factor RFX-B and its paralogue ANKRA2.

Alyssa Bushey Long1, Jeremy M Boss.   

Abstract

The extraordinary homology between major histocompatibility complex class II (MHC II) proteins across species from human to bony fish suggests that transcription factors that regulate these proteins might be conserved as well. Deficiencies in four proteins that regulate MHC II genes in humans (RFX-B, RFX5, RFXAP, and CIITA) cause an inherited immunodeficiency disorder known as the bare lymphocyte syndrome (BLS). To understand the structure and mechanism of function of the BLS transcription factors, we analyzed the evolutionary history of RFX-B, the factor deficient in the majority of patients with BLS. Sequence comparison and analysis of the RFX-B proteins showed that RFX-B and a closely related protein, ANKRA2, are present in humans to bony fish and that specific domains are highly conserved. In addition to sequence conservation, functional conservation exists, as mouse and Xenopus RFX-B orthologues, but not the paralogous protein ANKRA2, were able to complement the MHC II deficiency in a BLS-patient-derived cell line deficient in RFX-B. The remarkable conservation of the RFX-B lineage attests to the conservation of the regulation mechanism for this gene system and its importance to precisely regulate MHC class II molecules in both the developing and active immune response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655668     DOI: 10.1007/s00251-004-0738-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  33 in total

1.  Associations and interactions between bare lymphocyte syndrome factors.

Authors:  A M DeSandro; U M Nagarajan; J M Boss
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Characterization of ANKRA, a novel ankyrin repeat protein that interacts with the cytoplasmic domain of megalin.

Authors:  Katherine Rader; Robert A Orlando; Xiaojing Lou; Marilyn Gist Farquhar
Journal:  J Am Soc Nephrol       Date:  2000-12       Impact factor: 10.121

Review 3.  Insight into the primordial MHC from studies in ectothermic vertebrates.

Authors:  M F Flajnik; Y Ohta; C Namikawa-Yamada; M Nonaka
Journal:  Immunol Rev       Date:  1999-02       Impact factor: 12.988

4.  Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.

Authors:  N Nekrep; N Jabrane-Ferrat; B M Peterlin
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

5.  A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.

Authors:  K Masternak; E Barras; M Zufferey; B Conrad; G Corthals; R Aebersold; J C Sanchez; D F Hochstrasser; B Mach; W Reith
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

Review 6.  Birth of the major histocompatibility complex.

Authors:  J Klein; A Sato
Journal:  Scand J Immunol       Date:  1998-03       Impact factor: 3.487

7.  Identification of Gasz, an evolutionarily conserved gene expressed exclusively in germ cells and encoding a protein with four ankyrin repeats, a sterile-alpha motif, and a basic leucine zipper.

Authors:  Wei Yan; Aleksandar Rajkovic; Maria M Viveiros; Kathleen H Burns; John J Eppig; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2002-06

8.  RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.

Authors:  B Durand; P Sperisen; P Emery; E Barras; M Zufferey; B Mach; W Reith
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

9.  Genetic complexity of regulatory mutants defective for HLA class II gene expression.

Authors:  C Seidl; C Saraiya; Z Osterweil; Y P Fu; J S Lee
Journal:  J Immunol       Date:  1992-03-01       Impact factor: 5.422

10.  A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).

Authors:  V Steimle; B Durand; E Barras; M Zufferey; M R Hadam; B Mach; W Reith
Journal:  Genes Dev       Date:  1995-05-01       Impact factor: 11.361

View more
  3 in total

1.  New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.

Authors:  Michal Krawczyk; Krzysztof Masternak; Madeleine Zufferey; Emmanuèle Barras; Walter Reith
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

2.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.

Authors:  Suhani Thakker; Pravinkumar Purushothaman; Namrata Gupta; Shanthan Challa; Qiliang Cai; Subhash C Verma
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  Class II histone deacetylases confer signal responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK.

Authors:  Timothy A McKinsey; Koichiro Kuwahara; Svetlana Bezprozvannaya; Eric N Olson
Journal:  Mol Biol Cell       Date:  2005-10-19       Impact factor: 4.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.